Back to Insider Trading View Full Company Profile

GNLX

HEALTHY

GENELUX Corp

CIK: 0001231457

Sell (70% confidence)

Last activity: 6 days ago

Financial Metrics

As of Dec 31, 2025 (10-K)

Revenue $8K
Net Income -$32.15M
Total Cash $30.89M
Total Debt $900K
Debt/Equity 0.08
Current Ratio 2.43

Insider Roster (5 total, 5 active)

Insider Buys Sells Net Value Holdings
Thomas John
DIRECTOR
0 2 -$79K
482,784 shares
$1.40M
Zindrick Thomas
President and CEO
0 1 -$9K
534,849 shares
$1.29M
Smalling Ralph
Head of Regulatory
0 3 -$2K
68,073 shares
$171K
Yu Yong
SVP, Clinical Development
0 1 -$2K
144,938 shares
$351K
Cappello Joseph
Chief Technical Officer
0 1 -$2K
155,154 shares
$375K

Recent Transactions

SELL Smalling Ralph (Head of Regulatory)

240 shares @ $2.51

$602

Mar 25, 2026

Conviction: | View SEC Filing →
SELL Zindrick Thomas (President and CEO)

3,582 shares @ $2.42

$9K

Mar 24, 2026

Conviction: | View SEC Filing →
SELL Yu Yong (SVP, Clinical Development)

906 shares @ $2.42

$2K

Mar 24, 2026

Conviction: | View SEC Filing →
SELL Cappello Joseph (Chief Technical Officer)

906 shares @ $2.42

$2K

Mar 24, 2026

Conviction: | View SEC Filing →
SELL Smalling Ralph (Head of Regulatory)

345 shares @ $2.42

$835

Mar 24, 2026

Conviction: | View SEC Filing →
SELL Thomas John (DIRECTOR)

10,000 shares @ $2.90

$29K

Mar 2, 2026

Conviction: | View SEC Filing →
SELL Smalling Ralph (Head of Regulatory)

165 shares @ $4.69

$774

Dec 5, 2025

Conviction: | View SEC Filing →
SELL Thomas John (DIRECTOR)

10,000 shares @ $5.00

$50K

Dec 1, 2025

Conviction: | View SEC Filing →

⚠️ Important Disclaimer

• This is AI-generated analysis for educational purposes only, not financial advice.

• Insider trading data is derived from SEC Form 4 filings and may contain errors.

• Always conduct your own research and consult qualified financial advisors before making investment decisions.